Alaric J. Dyckman

1.2k citations

21 papers · 612 indexed · h-index 12

Co-authors: Paul A. Wender Claudia M. Barzilay Craig O. Husfeld Marc J. C. Scanio Heiko Rieck Dieter Kadereit Jennifer A. Love Katerina Leftheris
Topics: Catalytic Alkyne Reactions (5 papers)Melanoma and MAPK Pathways (5 papers)Cyclopropane Reaction Mechanisms (5 papers)
Cited by: Organic Chemistry Pharmaceutical Science Inorganic Chemistry
Journals: Journal of the American Chemical Society Nature Communications Journal of Medicinal Chemistry
Partner nations: United States India Germany

In The Last Decade

Alaric J. Dyckman

21 papers receiving 599 citations

Peers

Countries citing papers authored by Alaric J. Dyckman

Since Specialization

Citations

This map shows the geographic impact of Alaric J. Dyckman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alaric J. Dyckman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alaric J. Dyckman more than expected).

Fields of papers citing papers by Alaric J. Dyckman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alaric J. Dyckman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alaric J. Dyckman. The network helps show where Alaric J. Dyckman may publish in the future.

Co-authorship network of co-authors of Alaric J. Dyckman

This figure shows the co-authorship network connecting the top 25 collaborators of Alaric J. Dyckman. A scholar is included among the top collaborators of Alaric J. Dyckman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alaric J. Dyckman. Alaric J. Dyckman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Orthosteric STING inhibition elucidates molecular correction of SAVI STING 2025 ·Nature Communications ·Tao Xie,Max Ruzanov,David Critton,(unknown),Joseph G. Naglich,John S. Sack,Ping Zhang,(unknown),Jeffrey Tredup,(unknown),(unknown),(unknown),Janet Caceres‐Cortes,Luciano Mueller,Alaric J. Dyckman,John A. Newitt,(unknown),Stephen C. Wilson	2
2	AB0132 AFIMETORAN (BMS-986256), AN EQUIPOTENT TLR7/8 ANTAGONIST, DEMONSTRATES STEROID-SPARING EFFECTS IN A LUPUS MOUSE MODEL 2023 ·Annals of the Rheumatic Diseases ·(unknown),Puneet Chopra,A Rudra,(unknown),(unknown),Nilesh Bhatt,(unknown),Shatakshi Ranade,(unknown),Alaric J. Dyckman,Qihong Zhao	2
3	Identification of 2-Pyridinylindole-Based Dual Antagonists of Toll-like Receptors 7 and 8 (TLR7/8) 2022 ·ACS Medicinal Chemistry Letters ·(unknown),(unknown),Dharmpal S. Dodd,(unknown),Subramanya Hegde,Shana Posy,David Critton,Stefan Ruepp,Murali Subramanian,Luisa Salter–Cid,Debarati M. Tagore,(unknown),Shailesh Dudhgaonkar,Michael A. Poss,Gary L. Schieven,Percy H. Carter,John E. Macor,Alaric J. Dyckman	7
4	Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9) 2020 ·ACS Medicinal Chemistry Letters ·(unknown),Dharmpal S. Dodd,(unknown),(unknown),Honghe Wan,Shana Posy,David Critton,Stefan Ruepp,Murali Subramanian,Andrew J. Watson,Paul Davies,Gary L. Schieven,Luisa Salter–Cid,Ratika Srivastava,Debarati M. Tagore,Shailesh Dudhgaonkar,Michael A. Poss,Percy H. Carter,Alaric J. Dyckman	30
5	Aryl Ether-Derived Sphingosine-1-Phosphate Receptor (S1P₁) Modulators: Optimization of the PK, PD, and Safety Profiles 2020 ·ACS Medicinal Chemistry Letters ·Zili Xiao,Michael G. Yang,T. G. Murali Dhar,Hai‐Yun Xiao,John L. Gilmore,David Marcoux,Kim W. McIntyre,(unknown),Hong Shi,Paul Lévesque,Anthony M. Marino,Georgia Cornelius,Arvind Mathur,Ding Ren Shen,Mary Ellen Cvijic,Lois D. Lehman‐McKeeman,Huadong Sun,Jenny Xie,Percy H. Carter,Alaric J. Dyckman	4
6	Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P₁) Agonists and Future Perspectives 2017 ·Journal of Medicinal Chemistry ·Alaric J. Dyckman	45
7	Regioselective Epoxide Ring Opening for the Stereospecific Scale-Up Synthesis of BMS-960, A Potent and Selective Isoxazole-Containing S1P₁ Receptor Agonist 2017 ·Organic Process Research & Development ·(unknown),Huiping Zhang,Bang‐Chi Chen,Zhiwei Guo,Àmarjit Singh,Animesh Goswami,John L. Gilmore,James E. Sheppeck,Alaric J. Dyckman,Percy H. Carter,Arvind Mathur	20
8	An Efficient Scale-Up Synthesis of BMS-520, a Potent and Selective Isoxazole-Containing S1P₁ Receptor Agonist 2016 ·Organic Process Research & Development ·(unknown),Juliang Zhu,Bang‐Chi Chen,Scott H. Watterson,William J. Pitts,Alaric J. Dyckman,Percy H. Carter,Arvind Mathur,Huiping Zhang	11
9	Integrating High-Content Analysis into a Multiplexed Screening Approach to Identify and Characterize GPCR Agonists 2014 ·SLAS DISCOVERY ·Ying‐Jie Zhu,John B. Watson,Mengjie Chen,Ding Ren Shen,Melissa Yarde,(unknown),Neil T. Burford,Andrew Alt,Sukhanya Jayachandra,Mary Ellen Cvijic,Litao Zhang,Alaric J. Dyckman,Jenny Xie,Jonathan C. O’Connell,Martyn Banks,Andrea D. Weston	10
10	The identification of novel p38α isoform selective kinase inhibitors having an unprecedented p38α binding mode 2013 ·Bioorganic & Medicinal Chemistry Letters ·Stephen T. Wrobleski,Shuqun Lin,T. G. Murali Dhar,Alaric J. Dyckman,Tianle Li,Sidney Pitt,Rosemary Zhang,Yi Fan,Arthur M. Doweyko,John S. Tokarski,Kevin Kish,Susan E. Kiefer,John S. Sack,John A. Newitt,Mark R. Witmer,Murray McKinnon,Joel C. Barrish,John H. Dodd,Gary L. Schieven,Katerina Leftheris	15
11	Development of a Practical Synthesis of a p38 Kinase Inhibitor via a Safe and Robust Amination 2012 ·Organic Process Research & Development ·Zhongping Shi,Susanne Kiau,Paul C. Lobben,John Hynes,Hong Wu,Luca Parlanti,Robert P. Discordia,Wendel W. Doubleday,Katerina Leftheris,Alaric J. Dyckman,Stephen T. Wrobleski,(unknown),Srinivas Tummala,(unknown),(unknown)	12
12	Discovery of pyrrolo[2,1-f][1,2,4]triazine C6-ketones as potent, orally active p38α MAP kinase inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·Alaric J. Dyckman,Tianle Li,Sidney Pitt,Rosemary Zhang,Ding Ren Shen,Kim W. McIntyre,Kathleen M. Gillooly,David J. Shuster,Arthur M. Doweyko,John S. Sack,Kevin Kish,Susan E. Kiefer,John A. Newitt,Hongjian Zhang,Punit H. Marathe,Murray McKinnon,Joel C. Barrish,John H. Dodd,Gary L. Schieven,Katerina Leftheris	9
13	Imidazo[4,5-d]thiazolo[5,4-b]pyridine based inhibitors of IKK2: Synthesis, SAR, PK/PD and activity in a preclinical model of rheumatoid arthritis 2010 ·Bioorganic & Medicinal Chemistry Letters ·Alaric J. Dyckman,Charles M. Langevine,Claude Quesnelle,James Kempson,Junqing Guo,Patrice Gill,Steven H. Spergel,Scott H. Watterson,Tianle Li,David S. Nirschl,Kathleen M. Gillooly,Mark A. Pattoli,Kim W. McIntyre,(unknown),Murray McKinnon,John H. Dodd,Joel C. Barrish,James R. Burke,William J. Pitts	7
14	5-Amino-pyrazoles as potent and selective p38α inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Jagabandhu Das,Robert V. Moquin,Alaric J. Dyckman,Tianle Li,Sidney Pitt,Rosemary Zhang,Ding Ren Shen,Kim W. McIntyre,Kathleen M. Gillooly,Arthur M. Doweyko,John A. Newitt,John S. Sack,Hongjian Zhang,Susan E. Kiefer,Kevin Kish,Murray McKinnon,Joel C. Barrish,John H. Dodd,Gary L. Schieven,Katerina Leftheris	19
15	Synthesis, initial SAR and biological evaluation of 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine derived inhibitors of IκB kinase 2009 ·Bioorganic & Medicinal Chemistry Letters ·James Kempson,Junqing Guo,Jagabandhu Das,Robert V. Moquin,Steven H. Spergel,Scott H. Watterson,Charles M. Langevine,Alaric J. Dyckman,Mark A. Pattoli,James R. Burke,Xiao-Xia Yang,Kathleen M. Gillooly,Kim W. McIntyre,(unknown),John H. Dodd,Murray McKinnon,Joel C. Barrish,William J. Pitts	16
16	N-Amination of Pyrrole and Indole Heterocycles with Monochloramine (NH₂Cl) 2004 ·The Journal of Organic Chemistry ·John Hynes,Wendel W. Doubleday,Alaric J. Dyckman,Jollie D. Godfrey,John A. Grosso,Susanne Kiau,Katerina Leftheris	58
17	ChemInform Abstract: The First Intermolecular Transition Metal‐Catalyzed [5 + 2] Cycloadditions with Simple, Unactivated, Vinylcyclopropanes. 2001 ·ChemInform ·Paul A. Wender,Claudia M. Barzilay,Alaric J. Dyckman	1
18	The First Intermolecular Transition Metal-Catalyzed [5+2] Cycloadditions with Simple, Unactivated, Vinylcyclopropanes 2000 ·Journal of the American Chemical Society ·Paul A. Wender,Claudia M. Barzilay,Alaric J. Dyckman	136
19	A New and Practical Five-Carbon Component for Metal-Catalyzed [5 + 2] Cycloadditions: Preparative Scale Syntheses of Substituted Cycloheptenones 2000 ·Organic Letters ·Paul A. Wender,Alaric J. Dyckman,Craig O. Husfeld,Marc J. C. Scanio	65
20	Transition Metal-Catalyzed [5 + 2] Cycloadditions of 2-Substituted-1-vinylcyclopropanes: Catalyst Control and Reversal of Regioselectivity 1999 ·Organic Letters ·Paul A. Wender,Alaric J. Dyckman	63

About Alaric J. Dyckman

Alaric J. Dyckman is a scholar working on Organic Chemistry, Physiology and Computational Theory and Mathematics, having authored 21 papers that have together received 612 indexed citations. Recurring topics across this work include Catalytic Alkyne Reactions (5 papers), Melanoma and MAPK Pathways (5 papers) and Cyclopropane Reaction Mechanisms (5 papers). The work is most often cited by research in Organic Chemistry (471 citations), Pharmaceutical Science (20 citations) and Inorganic Chemistry (43 citations). Alaric J. Dyckman has collaborated with scholars based in United States, India and Germany. Frequent co-authors include Paul A. Wender, Claudia M. Barzilay, Craig O. Husfeld, Marc J. C. Scanio, Heiko Rieck, Dieter Kadereit, Jennifer A. Love, Katerina Leftheris, Susanne Kiau and Wendel W. Doubleday. Their work appears in journals such as Journal of the American Chemical Society, Nature Communications and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact